Association of a deficit of arousal with fatigue in multiple sclerosis: Effect of modafinil

Neuropharmacology

Volumn 64, Issue , 2013, Pages 380-388

  Niepel, Graham ^a   Bibani, Rashid H ^a   Vilisaar, Janek ^a   Langley, Robert W ^a   Bradshaw, Christopher M ^a   Szabadi, Elemer ^a   Constantinescu, Cris S ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Alertness; Fatigue; Modafinil; Multiple sclerosis; Sympathetic activity

Indexed keywords

GLATIRAMER; LACTOSE; MODAFINIL; PLACEBO; RECOMBINANT BETA INTERFERON;

ADRENERGIC STIMULATION; ADULT; ALERTNESS; AROUSAL; ARTICLE; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL FLICKER FUSION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DRUG EFFICACY; DRUG MECHANISM; EPWORTH SLEEPINESS SCALE; FATIGUE; FEMALE; HEART RATE; HUMAN; LOCUS CERULEUS; MALE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUPIL; PUPILLOGRAPHIC SLEEPINESS TEST; RESPONSE TIME; SCORING SYSTEM; SINGLE DRUG DOSE; SYSTOLIC BLOOD PRESSURE; VISUAL ANALOG SCALE; WAKEFULNESS;

ADULT; AROUSAL; AUTONOMIC NERVOUS SYSTEM; BENZHYDRYL COMPOUNDS; CARDIOVASCULAR AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NOOTROPIC AGENTS; PSYCHOMOTOR PERFORMANCE; SLEEP DISORDERS; SLEEP STAGES; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOMIMETICS;

EID: 84866383725     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.06.036     Document Type: Article

References (90)

1. K.A.J. Abduljawad, R.W. Langley, C.M. Bradshaw, and E. Szabadi Effects of clonidine and diazepam on the acoustic startle response and on its inhibition by 'prepulses' in man J. Psychopharmacol. 11 1997 29 34
2. A.K. Andreasen, J. Jakobsen, T. Petersen, and H. Andersen Fatigued patients with multiple sclerosis have impaired central muscle activation Mult. Scler. 15 2009 818 827
3. H.P. Attarian, K.M. Brown, S.P. Duntley, J.D. Carter, and A.H. Cross The relationship of sleep disturbances and fatigue in multiple sclerosis Arch. Neurol. 61 2004 525 528
4. R. Bakshi Fatigue associated with multiple sclerosis: diagnosis, impact and management Mult. Scler. 9 2003 219 227
5. R. Bakshi, Z.A. Shaikh, R.S. Miletich, D. Czarnecki, J. Dmochowski, K. Henschel, V. Janardhan, N. Dubey, and P.R. Kinkel Fatigue in multiple sclerosis and its relationship to depression and neurologic disability Mult. Scler. 6 2000 181 185
6. J.S. Ballon, and D. Feifel A systematic review of modafinil: potential clinical uses and mechanisms of action J. Clin. Psychiatry 67 2006 554 566
7. A.T. Beck, R.A. Steer, R. Ball, and W.F. Ranieri Comparison of Beck depression Inventories-IA and -II in psychiatric outpatients J. Personality Assess. 67 1996 588 597
8. J.A. Bobholz, and S.M. Rao Cognitive dysfunction in multiple sclerosis: a review of recent developments Curr. Opin. Neurol. 16 2003 283 288
9. A. Bond, and M. Lader The use of analogue scales in rating subjective feelings Brit. J. Med. Psychol. 47 1974 211 218
10. T.J. Braley, and R.D. Chervin Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment Sleep 33 2010 1061 1067
11. S.D. Brass, P. Duquette, J. Proulx-Therrien, and S. Auerbach Sleep disorders in patients with multiple sclerosis Sleep Med. Rev. 14 2010 121 129
12. A. Brioschi, S. Gramigna, E. Werth, F. Staub, C. Ruffieux, C. Bassetti, M. Schluep, and J.M. Annoni Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients Eur. Neurol. 62 2009 243 249
13. M. Bubser, J.R. Fadel, L.L. Jackson, J.H. Meador-Woodruff, D. Jing, and A.Y. Deutch Dopaminergic regulation of orexin neurons Eur. J. Neurosci. 21 2005 2993 3001
14. G. Comi, L. Leocani, P. Rossi, and B. Colombo Physiopathology and treatment of fatigue in multiple sclerosis J. Neurol. 248 2001 174 179
15. C.S. Constantinescu, G. Niepel, M. Patterson, A. Judd, M. Braitch, A.J. Fahey, S. Harikrishnan, L.J. Edwards, C.R. Tench, G.W. Bennett, and M. Ghatei Orexin A (hypocretin-1) levels are not reduced while cocaine/amphetamine regulated transcript levels are increased in the cerebrospinal fluid of patients with multiple sclerosis: no correlation with fatigue and sleepiness J. Neurol. Sci. 307 2011 127 131
16. W.C. Dement, J. Hall, and J.K. Walsh Tiredness versus sleepiness: semantics or a target for public education? Sleep 26 2003 485 486
17. A.Y. Deutch, M. Goldstein, and R.H. Roth Activation of the locus coeruleus induced by selective stimulation of the ventral tegmental area Brain Res. 363 1986 307 314
18. B. Elie, and J.P. Louboutin Sympathetic skin response (SSR) is abnormal in multiple sclerosis Muscle Nerve 18 1995 185 189
19. D.J. Ewing Analysis of heart rate variability and other non-invasive tests with special reference to diabetes mellitus R. Bannister, C.J. Mathias, Autonomic Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System third ed. 1992 Oxford University Press Oxford 667 689
20. L. Ferraro, T. Antonelli, W.T. O'Connor, S. Tanganelli, F.A. Rambert, and K. Fuxe Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers Biol. Psychiatry 42 1997 1181 1183
21. J. Fisk, P. Ritvo, L. Ross, D. Haase, T. Marrie, and W. Schlech Measuring the functional impact of fatigue: initial validation of the fatigue impact scale Clin. Infect. Dis. 8 1994 S79 S83
22. J.D. Fisk, and S.E. Doble Construction and validation of a fatigue impact scale for daily administration (D-FIS) Qual. of Life Res. 11 2002 263 272
23. P. Flachenecker, T. Kumpfel, B. Kallmann, M. Gottschalk, O. Grauer, P. Rieckmann, C. Trenkwalder, and K.V. Toyka Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters Mult. Scler. 8 2002 523 526
24. P. Flachenecker, A. Rufer, I. Bihler, C. Hippel, K. Reiners, K.V. Toyka, and J. Kesselring Fatigue in MS is related to sympathetic vasomotor dysfunction Neurology 61 2003 851 853
25. A. Freeman, B. Ciliax, R. Bakay, J. Daley, R.D. Miller, G. Keating, A. Levey, and D. Rye Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models Ann. Neurol. 50 2001 321 329
26. P. Gerrard, and R. Malcolm Mechanisms of modafinil: a review of current research Neuropsychiatr. Dis. Treat. 3 2007 349 364
27. G. Goodwin Mood disorder E.C. Johnstone, C.P.L. Freeman, A.K. Zealley, Companion to Psychiatric Studies sixth ed. 1998 Churchill Livingstone Edinburgh 399 430
28. C.A. Haensch, and J. Jörg Autonomic dysfunction in multiple sclerosis J. Neurol. 253 Suppl. 1 2006 I3 I9
29. I. Hindmarch Psychomotor function and psychoactive drugs Brit. J. Clin. Pharmacol. 10 1980 189 209
30. E. Hoddes, V. Zarcone, H. Smythe, R. Phillips, and W.C. Dement Quantification of sleepiness: a new approach Psychophysiology 10 1973 431 436
31. R. Hou, C. Freeman, R. Langley, E. Szabadi, and C. Bradshaw Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers Psychopharmacology 181 2005 537 549
32. R.H. Hou, R.W. Langley, E. Szabadi, and C.M. Bradshaw Comparison of diphenhydramine and modafinil on arousal and autonomic functions in healthy volunteers J. Psychopharmacol. 21 2007 567 578
33. T. Ishikuza, T. Murotani, and A. Yamatodani Modafinil activates the histaminergic system through the orexinergic neurons Neurosci. Lett. 483 2010 193 196
34. T. Ishikuza, T. Murotani, and A. Yamatodani Action of modafinil through histaminergic and orexinergic neurons Vitam. Horm. 89 2012 259 278
35. T. Ishikuza, Y. Sakamoto, T. Sakurai, and A. Yamatodani Modafinil increases histamine release in the anterior hypothalamus of rats Neurosci. Lett. 339 2003 143 146
36. V. Janardhan, and R. Bakshi Quality of life in patients with multiple sclerosis: the impact of fatigue and depression J. Neurol. Sci. 205 2002 51 58
37. M.W. Johns A new method for measuring daytime sleepiness: the Epworth sleepiness scale Sleep 14 1991 540 545
38. M. Kaminska, R.J. Kimoff, K. Schwartzman, and D.A. Trojan Sleep disorders and fatigue in multiple sclerosis: evidence for association and interaction J. Neurol. Sci. 302 2011 7 13
39. H. Kaynak, A. Altintaş, D. Kaynak, Ö. Uyanik, S. Saip, J. Agaoglu, G. Önder, and A. Siva Fatigue and sleep disturbance in multiple sclerosis Eur. J. Neurol. 13 2006 1333 1339
40. L.B. Krupp, L.A. Alvarez, N.G. LaRocca, and L.C. Scheinberg Fatigue in multiple sclerosis Arch. Neurol. 45 1988 435 437
41. L.B. Krupp, N.G. LaRocca, J. Muir-Nash, and A.D. Steinberg The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus Arch. Neurol. 46 1989 1121 1123
42. R. Lange, M. Volkmer, C. Heesen, and J. Liepert Modafinil effects in multiple sclerosis patients with fatigue J. Neurol. 256 2009 645 650
43. L. Leocani, B. Colombo, and G. Comi Physiopathology of fatigue in multiple sclerosis Neurol. Sci. 29 2008 241 243
44. J.-S. Lin, C. Anaclet, O. Sergeeva, and H. Haas The waking brain: an update Cell. Mol. Life Sci. 68 2011 2499 2512
45. E.T. Littleton, J.C. Hobart, and J. Palace Modafinil for multiple sclerosis fatigue: does it work? Clin. Neurol. Neurosurg. 112 2010 29 31
46. O. Lowenstein, R. Feinberg, and I.E. Loewenfeld Pupillary movements during acute and chronic fatigue Invest. Ophthalmol. 2 1963 138 157
47. J. Lu, T.C. Jhou, and C.B. Saper Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter J. Neurosci. 26 2006 193 202
48. F.D. Lublin, and S.C. Reingold Defining the clinical course of multiple sclerosis: results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis Neurology 46 1996 907 911
49. H. Lüdtke, B. Wilhelm, M. Adler, F. Schaeffel, and H. Wilhelm Mathematical procedures in data recording and processing of pupillary fatigue waves Vis. Res. 38 1998 2889 2896
50. W.S. MacAllister, and L.B. Krupp Multiple sclerosis-related fatigue Phys. Med. Rehab. Clinics North America 16 2005 483 502
51. B.K. Madras, Z. Xie, Z. Lin, A. Jassen, H. Panas, and L. Lynch Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro J. Pharmacol. Exp. Ther. 319 2006 561 569
52. W.I. McDonald, A. Compston, G. Edan, D. Goodkin, H.-P. Hartung, F.D. Lublin, H.F. McFarland, D.W. Paty, C.H. Polman, S.C. Reingold, M. Sandberg-Wollheim, W. Sibley, A. Thompson, S. Van Den Noort, B.Y. Weinshenker, and J.S. Wolinsky Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis Ann. Neurol. 50 2001 121 127
53. A.J. McDougall, and J.G. McLeod Autonomic nervous system function in multiple sclerosis J. Neurol. Sci. 215 2003 79 85
54. S. Merkelbach, C.A. Haensch, B. Hemmer, J. Koehler, N.H. König, and T. Ziemssen Multiple sclerosis and the autonomic nervous system J. Neurol. 253 Suppl. 1 2006 I21 I25
55. R. Mills, C. Young, J. Pallant, and A. Tennant Development of a patient reported outcome scale for fatigue in multiple sclerosis: the neurological fatigue index (NFI-MS) Health Quality Life Outcomes 8 2010 22
56. M.J. Minzenberg, and C.S. Carter Modafinil: a review of neurochemical actions and effects on cognition Neuropsychopharmacology 33 2008 1477 1502
57. M.J. Minzenberg, A.J. Watrous, J.H. Yoon, S. Ursu, and C.S. Carter Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI Science 322 2008 1700 1702
58. F. Möller, J. Poettgen, F. Broemel, A. Neuhaus, M. Daumer, and C. Heesen HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis Mult. Scler. 17 2011 1002 1009
59. G. Nagels, M.B. D'Hooghe, L. Vleugels, D. Kos, M. Despontin, and P.P. De Deyn P300 and treatment effect of modafinil on fatigue in multiple sclerosis J. Clin. Neurosci. 14 2007 33 40
60. J.L. Newton, O. Okonkwo, K. Sutcliffe, A. Seth, J. Shin, and D.E. Jones Symptoms of autonomic dysfunction in chronic fatigue syndrome QJM 100 2007 519 526
61. J. Noble, F. Forooghian, M. Sproule, C. Westall, and P. O'Connor Utility of the National Eye Institute VFQ-25 questionnaire in a heterogeneous group of multiple sclerosis patients Am. J. Ophthalmol. 142 2006 464 468
62. H. Norris The action of sedatives on brain stem oculomotor systems in man Neuropharmacology 10 1971 181 191
63. P.E. Polak, S. Kalinin, and D.L. Feinstein Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis Brain 134 2011 665 677
64. M.K. Racke, K. Hawker, and E.M. Frohman Fatigue in multiple sclerosis: is the picture getting simpler or more complex? Arch. Neurol. 61 2004 176 177
65. ®) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study J. Neurol. Neurosurg. Psychiatry 72 2002 179 183
66. S.M. Rao Cognitive function in patients with multiple sclerosis: impairment and treatment Int. J. MS Care 1 2004 9 22
67. P. Robertson Jr.; and E.T. Hellriegel Clinical pharmacokinetic profile of modafinil Clin. Pharmacokinet. 42 2003 123 137
68. E.R. Samuels, R.H. Hou, R.W. Langley, E. Szabadi, and C.M. Bradshaw Modulation of the acoustic startle response by the level of arousal: comparison of clonidine and modafinil in healthy volunteers Neuropsychopharmacology 32 2007 2405 2421
69. E.R. Samuels, and E. Szabadi Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function. Part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans Curr. Neuropharmacol 6 2008 254 285
70. E.O. Sanya, M. Tutaj, C.M. Brown, N. Goel, B. Neundorfer, and M.J. Hilz Abnormal heart rate and blood pressure responses to baroreflex stimulation in multiple sclerosis Clin. Auton. Res. 15 2005 213 218
71. C.B. Saper, and T.E. Scammell Modafinil: a drug in search of a mechanism Sleep 27 2004 11 12
72. J.E. Schwartz, L. Jandorf, and L.B. Krupp The measurement of fatigue: a new instrument J. Psychosom. Res. 37 1993 753 762
73. J.M. Smith, and H. Misiak Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects. A review Psychopharmacology 47 1976 175 182
74. B. Stankoff, E. Waubant, C. Confavreux, G. Edan, M. Debouverie, L. Rumbach, T. Moreau, J. Pelletier, C. Lubetzki, M. Clanet, and French Modafinil Study Group Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study Neurology 64 2005 1139 1143
75. E. Szabadi Drugs for sleep disorders: mechanisms and therapeutic prospects Brit. J. Clin. Pharmacol. 61 2006 761 766
76. E. Szabadi, G. Niepel, J. Vilisaar, R.W. Langley, C. Constantinescu, and C.M. Bradshaw Effects of modafinil on measures of alertness and psychomotor functions in multiple sclerosis J. Psychopharmacol. 22 5 2008 A33 Abstract Supplement to
77. E. Szabadi, G. Niepel, J. Vilisaar, R.W. Langley, C. Constantinescu, and C.M. Bradshaw Effects of modafinil on autonomic functions in multiple sclerosis J. Psychopharmacol. 23 6 2009 A59 Abstract Supplement to
78. E. Szabadi, and E.R. Samuels Stimulants: mechanisms and therapeutic prospects S.R. Pandi-Perumal, J.C. Verster, J.M. Monti, M. Lader, S.Z. Langer, Sleep Disorders: Diagnostics and Therapeutics 2008 Informa Healthcare UK London 281 294
79. I. Taneja, A. Diedrich, B.K. Black, D.W. Byrne, S.Y. Paranjape, and D. Robertson Modafinil elicits sympathomedullary activation Hypertension 45 2005 612 618
80. M.C. Tartaglia, S. Narayanan, S.J. Francis, A.C. Santos, N. De Stefano, Y. Lapierre, and D.L. Arnold The relationship between diffuse axonal damage and fatigue in multiple sclerosis Arch. Neurol. 61 2004 201 207
81. N. Téllez, J. Alonso, J. Río, M. Tintoré, C. Nos, X. Montalban, and A. Rovira The basal ganglia: a substrate for fatigue in multiple sclerosis Neuroradiology 50 2008 17 23
82. N.D. Volkow, J.S. Fowler, J. Logan, D. Alexoff, W. Zhu, F. Telang, G.-J. Wang, M. Jayne, J.M. Hooker, C. Wong, B. Hubbard, P. Carter, D. Warner, P. King, C. Shea, Y. Xu, L. Muench, and K. Apelskog-Torres Effectsmodafinil on dopamine and dopamine transporters in the male human brain JAMA 301 2009 1148 1154
83. B.G. Wallin Intraneural recordings of normal and abnormal sympathetic activity in man R. Bannister, C.J. Mathias, Autonomic Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System third ed. 1992 Oxford University Press Oxford 359 377
84. J.A. Wilken, C. Sullivan, M. Wallin, C. Rogers, R.L. Kane, H. Rossman, S. Lawson, J. Simsarian, C. Saunders, and M.E. Quig Treatment of multiple Sclerosis-related cognitive problems with adjunctive modafinil. Rationale and preliminary supportive data Int. J. MS Care 10 2008 1 10
85. J.P. Wisor, S. Nishino, I. Sora, G.H. Uhl, E. Mignot, and D.M. Edgar Dopaminergic role in stimulant-induced wakefulness J. Neurosci. 21 2001 1787 1794
86. K. Yoshida, S. McCormack, R.A. España, A. Crocker, and T.E. Scammell Afferents to the orexin neurons of the rat brain J. Comp. Neurol. 494 2006 845 861
87. R.E. Yoss, N.J. Moyer, and R.W. Hollenhorst Pupil size and spontaneous pupillary waves associated with alertness, drowsiness, and sleep Neurology 20 1970 545 554
88. U.A. Zifko Management of fatigue in patients with multiple sclerosis Drugs 64 2004 1295 1304
89. U.A. Zifko, M. Rupp, S. Schwarz, H.T. Zipko, and E.M. Maida Modafinil in treatment of fatigue in multiple sclerosis - results of an open-label study J. Neurol. 249 2002 983 987
90. D. Zolkowska, R. Jain, R.B. Rothman, J.S. Partilla, B.L. Roth, V. Setola, T.E. Prisinzano, and M.H. Baumann Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil J. Pharmacol. Exp. Ther. 329 2009 738 746